Click here for a full list of Dr. Oh’s publications.
18. Oh YM, Bacallao EA, Lee SA, Kim J, Swinford S, Smith GE, Britt B, Abdalla SM, and Lee SW. Identification of age-associated upstream regulators to promote neuronal resilience in HD patient-derived neurons. Neurosci. Bull. 2026. Accepted.
17. Langfelder P, Wang M, Ramanathan L, Oh YM, Lee SW, Gao F, Gu X, Stricos M, Plascencia M, Vaca R, Richman J, Coppola G, Vogt T, Horvath S, Yoo AS, Aaronson J, Rosinski J, and Yang XW. Systematic Heterozygosity Perturbations Identify HD Transcriptomic and Pathological Modifiers Including Scn4b, Kcnh4, and FoxP1. BioRxive. 2026. In Revision. doi: https://doi.org/10.64898/2026.03.02.709091
16. Lee SW, Upshaw TJ, Bailey DJ, Lee SA, Kim J, Joshi P, Smith GE, Swinford S, and Oh YM. CDKN1A Protects Medium Spiny Neurons from Huntington’s Disease Pathology. Neurobio. Dis. 2026. Sep. 227:107522. PMID: 42409247. https://doi.org/10.1016/j.nbd.2026.107522
15. Lee K, Shin B, Kim M, Lee SW, Oh YM, Kim KH, Jiang A, Ko K, Gillis T, Lucente D, Lee R, Kwak S, Lee JM, Wheeler VC, Yoo AS,
Gusella JF, MacDonald ME, and Seong IS. Genetic dissection of Huntington's disease modification by variation at RRM2B. Hum Mol Genet. 2025 Oct. 18;34(23):2004-2018. PMID: 41092345. https://doi.org/10.1093/hmg/ddaf150
14. Oh YM*, and Lee SW*. Patient-derived neuron model: Capturing age-dependent adult-onset degenerative pathology in Huntington's disease. Mol Cells. 2024 Apr. 47(4):100046. *co-corresponding authors. PMID: 38492889. https://doi.org/10.1016/j.mocell.2024.100046
13. Oh YM*, Lee SW*, and Yoo AS. Striatal neuronal models of HD through direct-conversion: modeling age-dependent disease phenotypes. Elsevier books, Huntington’s Disease. 2024 Feb. Paperback ISBN: 9780323956727, eBook ISBN: 9780323956734. *co-first authors. https://doi.org/10.1016/B978-0-323-95672-7.00012-1
12. Lee SW*, Oh YM*, Victor MB, Yang Y, Chen S, Strunilin I, Dahiya S, Dolle RE, Pak SC, Silverman GA, Perlmutter DH, and Yoo AS. Longitudinal modeling of human neuronal aging reveals the contribution of the RCAN1–TFEB pathway to Huntington’s disease neurodegeneration. Nat. Aging. 2024 Jan. 4:95-109. *co-first authors. PMID: 38066314. https://doi.org/10.1038/s43587-023-00538-3
11. Oh YM*, Lee SW*, and Yoo AS. Modeling Huntington disease through microRNA-mediated neural reprogramming identifies age-associated autophagy dysfunction driving the onset of neurodegeneration. Autophagy. 2023 Sep. 19(9):2613-2615. *co-first authors. PMID: 36727408. https://doi.org/10.1080/15548627.2023.2175572
10. Oh YM*, Lee SW*, Kim WK, Chen S, Church VA, Cates K, Li T, Zhang B, Dolle RE, Dahiya S, Pak SC, Silverman GA, Perlmutter DH, and Yoo AS. Age-related Huntington’s disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy. Nat. Neurosci. 2022 Nov. 25;1420-1433. *co-first authors. PMID: 36303071. https://doi.org/10.1038/s41593-022-01185-4
9. Lee SW, Oh YM, Lu Y, Kim WK, and Yoo AS. MicroRNAs overcome cell fate barrier by reducing EZH2-controlled REST stability during neuronal conversion of human adult fibroblasts. Dev. Cell. 2018 Jul. 2;73-4. PMID: 29974865. https://doi.org/10.1016/j.devcel.2018.06.007
8. Deng PY, Carlin D, Oh YM, Myrick LK, Warren ST, Cavalli V, Klyachko VA. (2019). Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of Fmr1 Knock-Out Mice. J Neurosci., 39(1):28-43.
7. Oh YM*, Mahar M*, Ewan EE, Leahy KM, Zhao G, Cavalli V. (2018). Epigenetic regulator UHRF1 inactivates REST and growth suppressor gene expression via DNA methylation to promote axon regeneration. Proc Natl Acad Sci U S A., 115(52): E12417-E12426. *co-first authors.
6. Lee SW, Oh YM, Lu YL, Kim WK, Yoo AS. (2018). MicroRNAs Overcome Cell Fate Barrier by Reducing EZH2-Controlled REST Stability during Neuronal Conversion of Human Adult Fibroblasts. Dev Cell., 46(1):73-84
5. Cho Y, Shin JE, Ewan EE, Oh YM, Pita-Thomas W, Cavalli V. (2015). Activating Injury-Responsive Genes with Hypoxia Enhances Axon Regeneration through Neuronal HIF-1α. Neuron., 88(4):720-34
4. Oh YM, Lee SB, Choi J, Suh HY, Shim S, Song YJ, Kim B, Lee JM, Oh SJ, Jeong Y, Cheong KH, Song PH, Kim KA. (2014). USP8 modulates ubiquitination of LRIG1 for Met degradation. Sci Rep., 4:4980.
3. Oh YM, Song Y-J, Lee SB, Jung Y, Kim B, Kim GW, Kim KE, Lee JM, Cho M-Y, Choi J, Nam D-H, Song PH, Cheong KH, Kim K-A. (2012). A new anti-c-Met antibody selected by a mechanism-based dual-screening method: therapeutic potential in cancer. Mol. Cells., 34:1-10.
2. Oh YM, Kwon YE, Kim JM, Bae SJ, Lee BK, Yoo SJ, Chung CH, Deshaies RJ, Seol JH. (2009). Chfr is linked to tumour metastasis through the downregulation of HDAC1. Nature Cell Biol.,11(3):295-302.
1. Oh YM, Yoo SJ, Seol JH. (2007). Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity. Biochem Biophys Res Commun., 8;357(3):615-9.